Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

424
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
424
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.7K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

58
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
58
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

451
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
451

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telehealth Utilization for Prostate Cancer Management in the Veteran Affairs Healthcare System: A Study from 2016 to 2023.

Journal of general internal medicine·2026
Same author

Beyond Public Health and Medicine: The Potential Impact of GLP-1s and Other Incretin Mimetic Medications on Greenhouse Gas Emissions.

Journal of public health management and practice : JPHMP·2026
Same author

MyLungHealth, a Patient-Facing Education Tool for Lung Cancer Screening: Qualitative User-Centered Design Study.

JMIR formative research·2026
Same author

Increasing reach of cancer care: provider perspectives on the value and use of teleoncology.

BMC health services research·2026
Same author

Decision-Making on Nicotine Replacement Therapy Use and Product Selection: An Explorative Qualitative Study Among Chinese Americans Who Smoke.

International journal of environmental research and public health·2026
Same author

Barriers and Enablers for Sustaining Nurse-Led Use of Clinical Decision Support Tools for Antibiotic Stewardship: Qualitative Study.

JMIR nursing·2026

Related Experiment Video

Updated: Oct 4, 2025

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

25.9K

A targeted approach to using e-cigarettes for harm reduction in adults.

Elizabeth R Stevens1, Scott E Sherman1

  • 1Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.

The American Journal of Drug and Alcohol Abuse
|February 7, 2022
PubMed
Summary

E-cigarettes (EC) show promise for smoking harm reduction in difficult-to-treat populations. Overcoming negative perceptions and research barriers is crucial for public health.

Keywords:
Harm reductionelectronic cigaretteshard-to-treatsmoking

More Related Videos

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.5K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.6K

Related Experiment Videos

Last Updated: Oct 4, 2025

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

25.9K
A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
09:30

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

Published on: January 18, 2018

8.5K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.6K

Area of Science:

  • Public Health
  • Tobacco Control
  • Harm Reduction

Background:

  • Smoking is the leading preventable cause of death in the US.
  • Negative perceptions of e-cigarettes (EC) and the belief they are as harmful as combustible cigarettes (CC) hinder public health efforts.
  • EC may offer a harm reduction strategy for smokers who have not succeeded with other cessation methods.

Purpose of the Study:

  • To advocate for overcoming the hostile research environment surrounding EC.
  • To explore the potential of EC as a harm reduction tool for hard-to-treat populations.
  • To address the public health opportunity missed due to negative EC perceptions.

Main Methods:

  • Literature review and synthesis of current research on EC and smoking cessation.
  • Analysis of public perception and media portrayal of EC.
  • Discussion of the potential role of EC in harm reduction strategies.

Main Results:

  • EC are harmful to adolescents and non-smokers.
  • Widespread belief that EC are as or more harmful than CC is inaccurate and detrimental.
  • EC possess significant potential for smoking harm reduction in specific populations.

Conclusions:

  • A more balanced research environment is needed to fully evaluate EC's harm reduction potential.
  • EC could be a valuable tool for hard-to-treat smokers.
  • Addressing misinformation about EC is critical for public health advancement.